Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 3546 entries
View as:

Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05398198 Org: User:
Start: 06/09/22 End: 04/09/24 Due: 04/09/25

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01506895 Org: User:
Start: 02/29/12 End: 02/28/13 Due: 02/28/14

Paracetamol With Caffeine to Treat Episodic Tension Type Headache

Phase: N/A Priority: Normal
NCT ID: NCT01755702 Org: User:
Start: 07/31/09 End: 03/31/10 Due: 03/31/11

To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function

Phase: N/A Priority: Normal
NCT ID: NCT03804710 Org: User:
Start: 01/22/19 End: 04/16/19 Due: 04/16/20

Lamotrigine Pregnancy Registry (LAM05)

Phase: N/A Priority: Normal
NCT ID: NCT01064297 Org: User:
Start: 11/30/01 End: 07/31/10 Due: 07/31/11

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00290303 Org: User:
Start: 05/31/04 End: 03/31/05 Due: 03/31/06

Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01153906 Org: User:
Start: 10/31/10 End: 09/30/13 Due: 09/30/14

A Study of GSK1325760A in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00424034 Org: User:
Start: 01/31/07 End: 02/28/07 Due: 02/28/08

Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02542813 Org: User:
Start: 09/14/15 End: 12/16/15 Due: 12/16/16

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04134728 Org: User:
Start: 10/31/19 End: 02/01/22 Due: 02/01/23

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00891761 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00089999 Org: User:
Start: 06/30/04 End: 03/31/08 Due: 03/31/09

Study of GSK2586881 on Acute Hypoxia and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT03000686 Org: User:
Start: 05/17/17 End: 01/04/19 Due: 01/04/20

Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00615212 Org: User:
Start: 01/02/08 End: 02/15/08 Due: 02/15/09

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02177812 Org: User:
Start: 08/27/14 End: 12/08/17 Due: 12/08/18

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Phase: N/A Priority: Normal
NCT ID: NCT05480800 Org: User:
Start: 09/13/22 End: 12/18/24 Due: 12/18/25

HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II

Phase: N/A Priority: Normal
NCT ID: NCT00291928 Org: User:
Start: 02/28/05 End: 09/30/07 Due: 09/30/08

A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01072214 Org: User:
Start: 03/09/10 End: 06/28/10 Due: 06/28/11

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00290342 Org: User:
Start: 01/01/06 End: 01/23/07 Due: 01/23/08

Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate

Phase: N/A Priority: Normal
NCT ID: NCT00102882 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01411111 Org: User:
Start: 01/06/11 End: 02/23/11 Due: 02/23/12

A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations.

Phase: N/A Priority: Normal
NCT ID: NCT04557371 Org: User:
Start: 10/12/20 End: 12/22/20 Due: 12/22/21

A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT04050722 Org: User:
Start: 10/07/19 End: 11/13/19 Due: 11/13/20

Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00158886 Org: User:
Start: 11/08/01 End: 08/11/06 Due: 08/11/07

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02033668 Org: User:
Start: 01/22/14 End: 07/15/14 Due: 07/15/15